Current approaches treatment for stress uriny incontinence in women

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Stress urinary incontinence (SUI) affects millions of women worldwide. Pelvic floor muscle training is the first-line treatment for SUI, and when ineffective, midurethral sling surgery becomes the gold standard of treatment. Recently, complications associated with the use of mesh prostheses, particularly chronic pain and dyspareunia, have become a major concern. Although traditional SUI treatments such as colposuspension and fascial slings are utilized, the future of SUI treatment is likely to depend on less invasive alternatives. Modern approaches such as volume-forming agents and laser treatment may have first-line treatment potential, but further long-term studies are needed. It is worth noting the increasing interest in the application of regenerative medicine and cellular technologies, but there is currently insufficient efficacy and safety data to recommend them in clinical practice. Patients should be involved in decision-making before any surgery to ensure that they are aware of the risks and treatment alternatives. Treatment should be selected on the basis of invasiveness and possible risks to provide women with the best individual treatment option.

Full Text

Restricted Access

About the authors

Andranik G. Vardikian

Federal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: a@urologufa.ru

assistant of the Department of Urology and Oncology 

Russian Federation, Ufa

Rustem A. Kazikhinurov

Federal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of the Ministry of Health of the Russian Federation

Email: royuro@mail.ru

Cand. Sci. (Med.), Associate Professor of the Department of Urology and Oncology

Russian Federation, Ufa

Anushavan O. Papoian

Federal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of the Ministry of Health of the Russian Federation

Email: anara_74@mail.ru

head of the Department of Urology Clinic, assistant of the Department of Urology and Oncology 

Russian Federation, Ufa

Diana R. Khabirova

Federal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of the Ministry of Health of the Russian Federation

Email: dianakhabirova13@list.ru

6th year student 

Russian Federation, Ufa

Bedil I. Shamsov

Federal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of the Ministry of Health of the Russian Federation

Email: bedilshamsov@mail.ru

postgraduate student of the Department of Urology and Oncology

Russian Federation, Ufa

Valentin N. Pavlov

Federal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of the Ministry of Health of the Russian Federation

Email: pavlov@bashgmu.ru

Rector, Academician of the Russian Academy of Medical Sciences, MD, Professor, Head of the Department of Urology and Oncology 

Russian Federation, Ufa

References

  1. Haylen B.T., Ridder D., Freeman R.M., Swift S.E., Berghmans B., Lee J. et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. International Urogynecology Journal and Pelvic Floor Dysfunction. 2010;21(1):5–26.
  2. Urinary incontinence in women: A methodological guide for patients / D.Y. Pushkar, G.R. Kasyan, L.A. Khodyreva et al. Moscow: State Budgetary Institution of the city of Moscow «Scientific Research Institute of Healthcare Organization and Medical Management of the Department of Healthcare of the City of Moscow», 2023. 16 p. Russian (Недержание мочи у женщин: Методическое пособие для пациентов / Д.Ю. Пушкарь, Г.Р. Касян, Л.А. Ходырева и др. Москва: Государственное бюджетное учреждение г. Москвы «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента» Департамента здравоохранения г. Москвы, 2023. 16 с.).
  3. Blaivas J.G., Olsson C.A. Stress incontinence: classification and surgical approach. Journal of Urology 1988;139(4):727‐31
  4. Agarwal B.K., Agarwal N. Urinary incontinence: prevalence, risk factors, impact on quality of life and treatment seeking behaviour among middle aged women. International Surgery Journal 2017;4(6):1953–8.
  5. Kasyan G.R., Sukhov S.O., Kupriyanov Yu.A. et al. Long-term results of using tension-controlled suburethral loop plastic surgery in the treatment of urinary incontinence. Experimental and clinical urology. 2023;16(2):160–164. doi: 10.29188/2222-8543-2023-16-2-160-164. – EDN XSHVQK. Russian (Касян Г.Р., Сухих С.О., Куприянов Ю.А. и др. Отдаленные результаты применения субуретральной петлевой пластики с контролем натяжения в лечении недержания мочи. Экспериментальная и клиническая урология. 2023;16(2):160–164. doi: 10.29188/2222-8543-2023-16-2-160-164. – EDN XSHVQK).
  6. Gvozdev M.Yu., Popov A.A., Bezhenar V.F. and others. Free synthetic loop: a preliminary analysis of the Russian experience from 2002 to 2012. Experimental and clinical urology. 2012;4:29–37. EDN PLNQSV. Russian (Гвоздев М.Ю., Попов А.А., Беженарь В.Ф. и др. Свободная синтетическая петля: предварительный анализ Российского опыта 2002-2012 гг. Экспериментальная и клиническая урология. 2012;4:29–37. EDN PLNQSV).
  7. Erema V.V., Buyanova S.N., Mgeliashvili M.V., Petrakova S.A., Puchkova N.V., Yudina N.V., Glebov T.A. MESH-associated complications in the correction of pelvic organ prolapse and stress urinary incontinence. Russian Bulletin of the obstetrician-gynecologist. 2021;21(3):74–78. Russian (Ерема В.В., Буянова С.Н., Мгелиашвили М.В., Петракова С.А., Пучкова Н.В., Юдина Н.В., Глебов Т.А. MESH-ассоциированные осложнения при коррекции пролапса тазовых органов и стрессовой формы недержания мочи. Российский вестник акушера-гинеколога. 2021;21(3):74–78).
  8. Chapple C.R., Cruz F., Deffieux X., Milani A.L., Arlandis S., Artibani W., Bauer R.M., Burkhard F., Cardozo L., Castro-Diaz D., Cornu J.N., Deprest J., Gunnemann A., Gyhagen M., Heesakkers J., Koelbl H., MacNeil S., Naumann G., Roovers J.W.R., Salvatore S., Sievert K.D., Tarcan T., Van der Aa F., Montorsi F., Wirth M., Abdel-Fattah M. Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. Eur Urol. 2017;72(3):424–431. doi: 10.1016/j.eururo.2017.03.048. Epub 2017 Apr 14. PMID: 28413126.
  9. Lapitan M.C.M., Cody J.D., Mashayekhi A. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 2017;7:CD002912
  10. Holdo B., Verelst M., Svenningsen R., Milsom I., Skjeldestad F.E. Longterm clinical outcomes with the retropubic tension-free vaginal tape (TVT) procedure compared to Burch colposuspension for correcting stress urinary incontinence (SUI). Int Urogynecol J. 2017;28: 1739–46.
  11. Laudano M.A., Seklehner S., Chughtai B. et al. Cost-effectiveness analysis of tension-free vaginal tape vs burch colposuspension for female stress urinary incontinence in the USA. BJU Int. 2013;112:E151–8.
  12. Kwon J., Kim Y., Kim D.Y. Second-Line Surgical Management After Midurethral Sling Failure. Int Neurourol J. 2021;25(2):111–118. doi: 10.5213/inj.2040278.139. Epub 2021 Mar 29. PMID: 33781060; PMCID: PMC8255818.
  13. Dean N., Ellis G., Herbison G.P., Wilson D., Mashayekhi A. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 2017;7:CD002239.
  14. Obaid AA, Al-Hamzawi SA, Alwan AA. Laparoscopic and open burch colposuspension for stress urinary incontinence: advantages and disadvantages. J Popul Ther Clin Pharmacol. 2022;29(2):e20-e26. doi: 10.47750/jptcp.2022.926. PMID: 35848193.
  15. Freites J., Stewart F., Omar M.I., Mashayekhi A., Agur W.I. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2019;12(12):CD002239. doi: 10.1002/14651858.CD002239.pub4. PMID: 31821550; PMCID: PMC6903454.
  16. Rehman H., Bezerra C.A., Bruschini H., Cody J.D., Aluko P. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7:CD001754.
  17. Ghoniem G.M., Rizk D.E.E. Renaissance of the autologous pubovaginal sling. Int Urogynecol J. 2018;29:177–78.
  18. Khan Z.A., Nambiar A., Morley R., Chapple C.R., Emery S.J., Lucas M.G. Long-term follow-up of a multicentre randomised controlled trial comparing tension-free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women. BJU Int. 2015;115:968–77.
  19. Kovalev G.V., Shkarupa D.D., Kubin N.D., Nichiporuk G.I., Gaivoronsky I.V. Anatomical prerequisites for the variability of the results of a transobturator medneurethral sling. Bulletin of Urology. 2021;9(2):64–73. https://doi.org/10.21886/2308-6424-2021-9-2-64-73. Russian (Ковалев Г.В., Шкарупа Д.Д., Кубин Н.Д., Ничипорук Г.И., Гайворонский И.В. Анатомические предпосылки вариативности результатов транс- обтураторного среднеуретрального слинга. Вестник урологии. 2021;9(2):64–73. https://doi.org/10.21886/2308-6424-2021-9-2-64-73).
  20. Itkonen Freitas A.M., Rahkola-Soisalo P., Mikkola T.S., Mentula M. Current treatments for female primary stress urinary incontinence. Climacteric. 2019;22(3):263–269. doi: 10.1080/13697137.2019.1568404. Epub 2019 Feb 18. PMID: 30773062.
  21. Fusco F., Abdel-Fattah M., Chapple C.R. et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol 2017; 72:567–91.
  22. Bakas P., Papadakis E., Karachalios C., Liapis I., Panagopoulos N., Liapis A. Assessment of the long-term outcome of TVT procedure for stress urinary incontinence in a female population: results at 17 years’ follow-up. Int Urogynecol J 2018. Epub ahead of prin.
  23. Zhang Y., Song X., Mao M., Kang J., Ai F, Zhu L. Tension-free vaginal tape for the treatment of stress urinary incontinence: a 13-year prospective follow-up. J Minim Invasive Gynecol 2018. pii:S1553–4650(18)30425-4.
  24. Serati M., Braga A., Athanasiou S. et al. Tension-free Vaginal tape–obturator for treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects at 10-year follow-up. Eur Urol. 2017;71:674–79.
  25. Serdinsek T., But I. Long-term results of two different trans-obturator techniques for surgical treatment of women with stress and mixed urinary incontinence: a 10-year randomised controlled study follow-up. Int Urogynecol J 2018. Epub ahead of print.
  26. Zhang Y., Song X., Zhang Z. et al. Tension-free vaginal tape-obturator for the treatment of stress urinary incontinence: a 12-year prospective follow-up. BJU Int 2018. Epub ahead of print.
  27. Tommaselli G.A., Di Carlo C., Formisano C., Fabozzi A., Nappi C. Medium-term and long-term outcomes following placement of midurethral slings for stress urinary incontinence: a systematic review and metaanalysis. Int Urogynecol J 2015;26:1253–68.
  28. Costantini E., Kocjancic E., Lazzeri M. et al. Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial. World J Urol. 2016;34:585–93.
  29. Ford A.A., Rogerson L., Cody J.D., Aluko P., Ogah J.A. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017;7:CD006375.
  30. Goodall E.J., Cartwright R., Stratta E.C., Jackson S.R., Price N. Outcomes after laparoscopic removal of retropubic midurethral slings for chronic pain. Int Urogynecol. J 2018. Epub ahead of print.
  31. Loran O.B., Seregin A.V., Dovlatov Z.A. Short-, medium- and long-term efficacy and safety indicators of sling operations for urinary incontinence in women. Bulletin of Urology. 2020;8(4):80–92. doi: 10.21886/2308-6424-2020-8-4-80-92. EDN FFLTRF. Russian (Лоран О.Б., Серегин А.В., Довлатов З.А. Кратко-, средне- и долгосрочные показатели эффективности и безопасности слинговых операций при недержании мочи у женщин. Вестник урологии. 2020;8(4):80–92. doi: 10.21886/2308-6424-2020-8-4-80-92. EDN FFLTRF).
  32. Cardot V., Campagne-Loiseau S., Roulette P., Peyrat L., Vidart A., Wagner L., Thuillier C., Klap J., Hurel S., Hermieu J.F., Girard F., Even L., Donon L., Charles T., Tibi B., Bosset P.O., Berrogain N., Meyer F., Cornu J.N., Deffieux X. 2021 opinion from the CUROPF on THE efficacy and safety of mid-urethral slings used in women WITH urinary stress incontinence. Prog Urol. 2022;32(4):247–257. doi: 10.1016/j.purol.2021.10.012. Epub 2021 Dec 14. PMID: 34920924.
  33. Zbinden M., Stritt K., Jichlinski P., Grilo N. Actualité du traitement chirurgical de l’incontinence urinaire d’effort chez la femme [Current surgical treatments for women with stress urinary incontinence]. Rev Med Suisse. 2019;15(673):2186–2189. French. PMID: 31778046.
  34. Nambiar A., Cody J.D., Jeffery S.T., Aluko P.. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7:CD008709.
  35. Bezhenar V.F., Arakelyan B.V., Krutova V.A., Tarabanova O.V., Khachetsukova A.A., Turlak A.S. The use of volume-forming substances in the treatment of stress urinary incontinence. Kuban Scientific Medical Bulletin. 2019;26(4):84–93. https://doi.org/10.25207/1608-6228-2019-26-4-84-93. Russian (Беженарь В.Ф., Аракелян Б.В., Крутова В.А., Тарабанова О.В., Хачецукова А.А., Турлак А.С. Применение объемообразующих веществ в лечении стрессового недержания мочи. Кубанский научный медицинский вестник. 2019;26(4):84–93. https://doi.org/10.25207/1608-6228-2019-26-4-84-93).
  36. Klarskov N., Lose G. Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn. 2008;27:789–92.
  37. Kasi A.D., Pergialiotis V., Perrea D.N., Khunda A., Doumouchtsis S.K. Polyacrylamide hydrogel (BulkamidVR ) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol. J 2016;27:367–75.
  38. Kirchin V., Page T., Keegan P.E., Atiemo K., Cody J.D., McClinton S.Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2012;CD003881.
  39. Sokol E.R., Karram M.M., Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study. J Urol. 2014;192:843–9.
  40. Itkonen Freitas A.M., Mentula M., Rahkola-Soisalo P., Tulokas S., Mikkola T.S. Tension-Free Vaginal Tape Surgery versus Polyacrylamide Hydrogel Injection for Primary Stress Urinary Incontinence: A Randomized Clinical Trial. J Urol. 2020 Feb;203(2):372-378. doi: 10.1097/JU.0000000000000517. Epub 2019 Sep 3. PMID: 31479396.
  41. Kuszka A., Gamper M., Walser C., Kociszewski J., Viereck V. Erbium:YAG laser treatment of female stress urinary incontinence: Midterm data. Int. Urogynecol. J. 2020;31:1859–1866. doi: 10.1007/s00192-019-04148-9.
  42. Kuszka A., Gamper M., Walser C., Kociszewski J., Viereck V. Erbium:YAG laser treatment of female stress urinary incontinence: Midterm data. Int. Urogynecol. J. 2020;31:1859–1866. doi: 10.1007/s00192-019-04148-9.
  43. Erel C.T., Gambacciani M., Ozcivit Erkan I.B., Gokmen Inan N., Hamzaoglu Canbolat K., Fidecicchi T. SUI in postmenopausal women: Advantages of an intraurethral + intravaginal Er:YAG laser. Climacteric. 2023;26:503–509. doi: 10.1080/13697137.2023.2210282.
  44. Tseng Y.L., Su C.F. Efficacy and safety of intraurethral Erbium:YAG laser treatment in women with stress urinary incontinence following failed intravaginal laser therapy: A retrospective study. Lasers Med. Sci. 2023;38:207. doi: 10.1007/s10103-023-03872-5.
  45. Okui N., Erel T., Okui M.A. Analysis of predictive factors for return to sports in female athletes with stress urinary incontinence. Cureus. 2023;15:e44364. doi: 10.7759/cureus.44364.
  46. Erel C.T., Inan D., Mut A. Predictive factors for the efficacy of Er:YAG laser treatment of urinary incontinence. Maturitas. 2020;132:1–6. doi: 10.1016/j.maturitas.2019.11.003.
  47. Fistonic N., Fistonic I., Lukanovic A., Findri Gustek S., Sorta Bilajac Turina I., Franic D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: Prospective cohort study. Climacteric. 2015;18((Suppl. S1)):37–42. doi: 10.3109/13697137.2015.1071126.
  48. Luvero D., Angioli R., Baruch Y., Salvatore S., Filippini M., Pieralli A., Montera R. The efficacy and feasibility of fractional CO2 laser therapy for the treatment of urinary incontinence: A multicentric case-control study. Minerva Obstet. Gynecol. 2023 doi: 10.23736/S2724-606X.23.05290-9.
  49. Montera R., Ficarola F., Angioli R., Terranova C., Nardone C.C., Guzzo F., Plotti F., Luvero D. Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence. Neurourol. Urodyn. 2023;42:393–400. doi: 10.1002/nau.25112.
  50. Ruffolo A.F., Casiraghi A., Marotta E., Degliuomini R., Parma M., Athanasiou S., Benini V., Candiani M., Salvatore S. Does the time of onset of urinary symptoms affect microablative fractional CO2 laser efficacy in postmenopausal women? Lasers Surg. Med. 2021;53:953–959. doi: 10.1002/lsm.23378.
  51. Franic D., Fistonic I. Laser therapy in the treatment of female urinary incontinence and genitourinary syndrome of menopause: An update. BioMed Res. Int. 2019;2019:1576359. doi: 10.1155/2019/1576359.
  52. Gaspar A., Brandi H. Non-ablative Erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency) Lasers Med. Sci. 2017;32:685–691. doi: 10.1007/s10103-017-2170-5.
  53. Wang Y., Wang C., Song F., Zhou Y., Wang Y. Safety and efficacy of vaginal laser therapy for stress urinary incontinence: a meta-analysis. Ann Palliat Med. 2021 Mar;10(3):2736-2746. doi: 10.21037/apm-20-1440. Epub 2021 Jan 26. PMID: 33549008.
  54. Okui N., Miyazaki H., Takahashi W., Miyauchi T., Ito C., Okui M., Shigemori K., Miyazaki Y., Vizintin Z., Lukac M. Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis. Lasers Med Sci. 2022 Feb;37(1):655-663. doi: 10.1007/s10103-021-03317-x. Epub 2021 Apr 22. PMID: 33886071; PMCID: PMC8803680.
  55. Klap J., Campagne-Loiseau S., Berrogain N., Bosset P.O., Cardot V., Charles T., Deffieux X., Donon L., Girard F., Peyrat L., Roulette P., Thuillier C., Tibi B., Vidart A., Wagner L., Hermieu J.F., Cornu J.N. et le Comité d’Urologie et de Pelviperinéologie de la Femme (CUROPF) de l’Association Française d’Urologie. Utilisation du LASER vaginal pour le traitement des pathologies génito-urinaires : revue systématique de la littérature et position du CUROPF [Vaginal LASER therapy for genito-urinary disorders: A systematic review and statement from the Committee for Female Urology and Pelviperineology of the French Association of Urology]. Prog Urol. 2021 Sep;31(11):634-650. French. doi: 10.1016/j.purol.2020.11.003. Epub 2021 Jan 28. PMID: 33516611.
  56. Barakat B., Franke K., Schakaki S., Hijazi S., Hasselhof V., Vögeli T.A. Stem cell applications in regenerative medicine for stress urinary incontinence: A review of effectiveness based on clinical trials. Arab J Urol. 2020;18(3):194–205. doi: 10.1080/2090598X.2020.1750864. PMID: 33029431; PMCID: PMC7473152.
  57. Aragon I.M., Imbroda B.H., Lara M.F. Cell therapy clinical trials for stress urinary incontinence: current status and perspectives. Int J Med Sci 2018;15:195–204.
  58. Михельсон А.А., Лазукина М.В., Усова Е.В. и др. Современные представления о диагностике и лечении стрессового недержания мочи у женщин. Лечение и профилактика. 2021;11(1):52–62. EDN RSEOQW.
  59. Denisenko A.A., Clark C.B., D’Amico M., Murphy A.M. Evaluation and management of female urinary incontinence. Can J Urol. 2021;28(S2):27–32. PMID: 34453426.
  60. MacCraith E., Cunnane E.M., Joyce M., Forde J.C., O’Brien F.J., Davis N.F. Comparison of synthetic mesh erosion and chronic pain rates after surgery for pelvic organ prolapse and stress urinary incontinence: a systematic review. Int Urogynecol J. 2021;32(3):573–580. doi: 10.1007/s00192-020-04612-x. Epub 2020 Nov 25. PMID: 33237357.
  61. Cardot V., Campagne-Loiseau S., Roulette P., Peyrat L., Vidart A., Wagner L., Thuillier C., Klap J., Hurel S., Hermieu J.F., Girard F., Even L., Donon L., Charles T., Tibi B., Bosset P.O., Berrogain N., Meyer F., Cornu J.N., Deffieux X. 2021 opinion from the CUROPF on THE efficacy and safety of mid-urethral slings used in women WITH urinary stress incontinence. Prog Urol. 2022;32(4):247–257. doi: 10.1016/j.purol.2021.10.012. Epub 2021 Dec 14. PMID: 34920924.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Bionika Media